IP Library Granted Patent US 8,945,895
Granted Patent B2
US 8,945,895 · App. 12/847,956 · Granted Feb 3, 2015

Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,945,895
App. No.
12/847,956
Granted
Feb 3, 2015
Kind
B2
Abstract

Provided herein are methods for purifying recombinant A Disintegrin-like and Metallopeptidase with Thrombospondin Type 1 Motif 13 (ADAMTS13) protein from a sample. The method comprises enriching for ADAMTS13 protein by chromatographically contacting the sample with hydroxyapatite under conditions that allow ADAMTS13 protein to appear in the eluate or supernatant from the hydroxylapatite. The methods may further comprise tandem chromatography with a mixed mode cation exchange/hydrophobic interaction resin that binds ADAMTS13 protein. Additional optional steps involve ultrafiltration/diafiltration, anion exchange chromatography, cation exchange chromatography, and viral inactivation. Also provided herein are methods for inactivating virus contaminants in protein samples, where the protein is immobilized on a support. Also provided herein are compositions of ADAMTS13 prepared according to said methods.

Claims (22)

1. A method for purifying recombinant a disintegrin-like and metallopeptidase with thrombospondin type I motif 13 (ADAMTS13) protein from a sample comprising ADAMTS13 protein and non-ADAMTS13 impurities, the method comprising the steps of:

(a) chromatographically contacting the sample with hydroxyapatite under conditions that allow said ADAMTS13 protein to appear in a flow through fraction from said hydroxyapatite by said ADAMTS13 protein not binding to said hydroxyapatite while said non-ADAMTS13 impurities are retained on said hydroxyapatite;

(b) subsequently chromatographically contacting said flow through fraction with a mixed mode cation exchange/hydrophobic interaction resin that hinds said ADAMTS13 protein; and

(c) eluting said ADAMTS13 protein from said mixed mode cation exchange/hydrophobic interaction resin with an elution buffer.

2. The method according to claim 1 , further comprising chromatographically contacting said sample with an anion exchange resin and eluting said ADAMTS13 protein from said anion exchange resin before step (a) chromatographic contact with said hydroxyapatite.

3. The method according to claim 1 , further comprising concentrating said ADAMTS13 protein in said sample by ultrafiltration; and stabilizing said ADAMTS13 protein by diafiltration exchange into a buffer comprising calcium ions and zinc ions before step (a) chromatographic contact with said hydroxyapatite.

4. The method according to claim 1 , further comprising, following contact with in step (a) said hydroxyapatite or in step (g) said mixed mode cation exchange/hydrophobic interaction resin, a preparing step (d) for preparing said ADAMTS13 protein for cation exchange by reducing buffer conductivity.

5. The method according to claim 4 , wherein said preparing step (d) is performed by ultrafiltration/diafiltration.

6. The method according to claim 4 , wherein said preparing step (d) is performed by dialysis, said dialysis being performed once or twice.

7. The method according to claim 5 , wherein said preparing step (d) is performed by gel filtration.

8. The method according to claim 4 , further comprising subjecting said ADAMTS13 protein to at least one virus inactivation or virus removal step (e), wherein said virus inactivation or virus removal step is performed after said preparing step (d).

9. The method according to claim 1 or 4 , further comprising subjecting said ADAMTS13 protein to at least one virus inactivation or virus removal step (e).

10. The method according to claim 9 , Wherein said virus inactivation step (e) comprises adding a solvent-detergent mixture comprising a non-ionic detergent and an organic solvent to said ADAMTS13 protein.

11. The method according to claim 9 , wherein said virus removal step (e) comprises filtering said ADAMTS13 protein with a nanofilter to remove viruses and/or viral particles.

12. The method according to claim 10 , wherein said ADAMTS13 protein is immobilized during said virus inactivation step (e).

13. The method according to claim 10 , wherein said solvent-detergent mixture comprises 1% TRITONX-100, 0.3% Tri-N-butyl phosphate, and 0.3% TWEEN 80.

14. The method according to claim 12 , wherein said ADAMTS13 protein is in step (e) immobilized on a cation exchange resin.

15. The method according to claim 14 , further comprising eluting said ADAMTS13 protein from said cationic exchange resin using gradient elution, said gradient elution comprising using a first buffer having low salt content and a second buffer having higher salt content.

16. The method according to claim 14 , further comprising eluting said ADAMTS13 protein from said cationic exchange resin using step elution.

17. The method according to claim 16 , wherein said step elution comprises eluting said ADAMTS13 protein from said cationic exchange resin with a storage buffer.

18. The method according to claim 17 , wherein said storage buffer has a pH of greater than 7.0 and comprises less than 10 mM calcium ions, a buffering compound, 0.05% non-ionic detergent, and a salt.

19. The method according to claim 17 , wherein there is no ultrafiltration, diafiltration or buffer exchange step subsequent to the eluting step from the cation exchange resin with the storage buffer.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055188/0953 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTIES NAME PREVIOUSLY RECORDED AT REEL: 036360 FRAME: 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 17, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036621/0554 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER HEALTHCARE S.A.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036360/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036373/0426 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2010
From: HASSLACHER, MEINHARD; FIEDLER, CHRISTIAN; MAYER, CHRISTA; MITTERER, ARTUR
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 025533/0257 →